Posted on 10/30/2024
Cushing's syndrome, or hyperadrenocorticism (HAC), is one of the most common endocrine diseases in dogs, affecting approximately 1-2 dogs per 1,000 (Schofield et al., 2022). Virbac Launches Trilotab, the first chewable, flavoured and divisible Tri
Cushing's syndrome, or hyperadrenocorticism (HAC), is one of the most
common endocrine diseases in dogs, affecting approximately 1-2 dogs per 1,000
(Schofield et al., 2022). Virbac Launches Trilotab, the first chewable, flavoured and
divisible Trilostane tablet to treat Cushing's Syndrome in dogs.
Canine Cortisol Test Kit of JZ Biotech will be able to diagnose endoc...